Stemtech (STEK) Cash & Equivalents Growth (3y) (2015 - 2025)

Stemtech (STEK) Cash & Equivalents Growth (3y) (2015 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (3y) (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn 20.41%
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn -2.73%
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn 3.22%
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn -49.65%
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn 36.93%
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn 10.41%
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn 3.03%
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn 1.92%
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn 65.82%
10 Stemtech - - 354,677.00 21.60%

Historic Data

Download Data
DateValue
Dec 31, 2025 21.60%
Sep 30, 2025 27.55%
Jun 30, 2025 -12.00%
Mar 31, 2025 -15.74%
Dec 31, 2024 -32.45%
Sep 30, 2024 -45.44%
Nov 30, 2020 -22.70%
Aug 31, 2020 -36.30%
May 31, 2020 -44.76%
Feb 29, 2020 66.59%
Nov 30, 2019 3.43%
Aug 31, 2019 -42.13%
May 31, 2019 -29.55%
Feb 28, 2019 -23.09%
Nov 30, 2018 -9.44%
Aug 31, 2018 115.95%
May 31, 2018 80.84%
Feb 28, 2018 -26.81%
Nov 30, 2017 -12.62%
Aug 31, 2017 -21.92%